Target safety assessments and their role in de-risking drug discovery: NaV1.7 as an example

被引：0
|
作者：
Eades, Lauren [1 ]
Sadler, Claire [1 ]
Knight, Richard [1 ]
Morton, Michael [1 ]
Roberts, Ruth [1 ]
机构：
[1] ApconiX, Alderley Edge, England
来源：
TOXICOLOGY LETTERS | 2017年 / 280卷
关键词：
D O I：
10.1016/j.toxlet.2017.07.620
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P-07-03-1
引用
收藏
页码：S224 / S225
页数：2
相关论文
共 12 条
  • [1] De-Risking Drug Discovery with ADDME - Avoiding Drug Development Mistakes Early
    Tsaioun, Katya
    Jacewicz, Mary
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2009, 37 : 47 - 55
  • [2] The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement
    La, Daniel S.
    Peterson, Emily A.
    Bode, Christiane
    Boezio, Alessandro A.
    Bregman, Howard
    Chu-Moyer, Margaret Y.
    Coats, James
    DiMauro, Erin F.
    Dineen, Thomas A.
    Du, Bingfan
    Gao, Hua
    Graceffa, Russell
    Gunaydin, Hakan
    Guzman-Perez, Angel
    Fremeau, Robert, Jr.
    Huang, Xin
    Ilch, Christopher
    Kornecook, Thomas J.
    Kreiman, Charles
    Ligutti, Joseph
    Lin, Min-Hwa Jasmine
    McDermott, Jeff S.
    Marx, Isaac
    Matson, David J.
    McDonough, Stefan I.
    Moyer, Bryan D.
    Nguyen, Hanh Nho
    Taborn, Kristin
    Yu, Violeta
    Weiss, Matthew M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3477 - 3485
  • [3] A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7
    Trombetti, Gabriele A.
    Mezzelani, Alessandra
    Orro, Alessandro
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [4] Structure-based drug discovery in a sodium channel: Discovery of chromane arylsulfonamide Nav1.7 inhibitors for the treatment of chronic pain
    McKerrall, Steven
    Bergeron, Philippe
    Safina, Brian
    Ortwine, Daniel
    Shields, Shannon
    Deng, Lunbin
    Hackos, David
    Chen, Jun
    Pang, Jodie
    Chang, Jae
    Lai, Kwong
    Liu, Wenfeng
    Liu, Zhiguo
    Dehnhardt, Christoph
    Johnson, J. P.
    Bankar, Girish
    Cohen, Charles
    Sutherlin, Daniel
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [5] Development of a neuronal scoring systemin vitro for potential hazard identification in early drug safety de-risking
    Kreir, Mohamed
    Putri, Dea
    Tekle, Fetene
    Van Ammel, Karel
    Lu, Hua Rong
    Teisman, Ard
    Gallacher, David J.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [6] De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive Hits
    Ng, Simon
    Juang, Yu-Chi
    Chandramohan, Arun
    Kaan, Hung Yi Kristal
    Sadruddin, Ahmad
    Yuen, Tsz Ying
    Ferrer-Gago, Fernando J.
    Lee, Xue'Er Cheryl
    Liew, Xi
    Johannes, Charles W.
    Brown, Christopher J.
    Kannan, Srinivasaraghavan
    Aronica, Pietro G.
    Berglund, Nils A.
    Verma, Chandra S.
    Liu, Lijuan
    Stoeck, Alexander
    Sawyer, Tomi K.
    Partridge, Anthony W.
    Lane, David P.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1993 - 2001
  • [7] De-risking in Tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observers
    Gauvin, David, V
    Zimmermann, Zachary J.
    Dalton, Jill A.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2022, 129
  • [8] Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach
    Klint, Julie K.
    Smith, Jennifer J.
    Vetter, Irina
    Rupasinghe, Darshani B.
    Er, Sing Yan
    Senff, Sebastian
    Herzig, Volker
    Mobli, Mehdi
    Lewis, Richard J.
    Bosmans, Frank
    King, Glenn F.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (10) : 2445 - 2458
  • [9] Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking
    Kopljar, Ivan
    Lu, Hua Rong
    Van Ammel, Karel
    Otava, Martin
    Tekle, Fetene
    Teisman, Ard
    Gallacher, David J.
    [J]. STEM CELL REPORTS, 2018, 11 (06): : 1365 - 1377
  • [10] DE-RISKING IDIOSYNCRATIC ADVERSE DRUG REACTIONS AND TOXICITIES IN DRUG DISCOVERY UTILIZING A QUALITATIVE IN-VITRO HIGH-THROUGHPUT REACTIVE METABOLITE TRAPPING METHOD
    Roychowdhury, Shantanu
    Thomas, Kevin
    Liverar, Allison
    Martineau, Michell
    Bell, Libby
    Albrecht, Lucus
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
12